Gray Michael
- SEC CIK
- 0001271411
In the past year, 3 open-market sale filings worth $17.8K and no purchases.
Current role at each company
- UPB Upstream Bio, Inc.CFO and COOas of Sep 17, 2026
- ELVN Enliven Therapeutics, Inc.CFO & COOas of Feb 22, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $17.8K
- 3 filings
- Net
- −$17.8K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Gray Michael as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
UPB Upstream Bio, Inc.
CFO and COO3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 17, 2026 (view filing)4:05 PM ET | Sep 16 | 1 day | Gray MichaelCFO and COO | SSale | −853 | $5.49 | −$4.68K | −3.0%27.9K after | |
| Jun 17, 2026 (view filing) | Jun 16 | 1 day | Gray MichaelCFO and COO | SSale | −853 | $6.10 | −$5.20K | −2.9%28.8K after | |
| Mar 17, 2026 (view filing) | Mar 16 | 1 day | Gray MichaelCFO and COO | SSale | −852 | $9.29 | −$7.92K | −2.8%29.6K after |
ELVN Enliven Therapeutics, Inc.
CFO & COO2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 22, 2023 (view filing) | Feb 22 | Same day | Gray MichaelCFO & COO | SSale | −9.86K | $4.67 | −$46.0K | −26.3%27.6K after | |
| Feb 1, 2023 (view filing) | Jan 30 | 2 days | Gray MichaelCFO & COO | SSale | −3.60K | $3.92 | −$14.1K | −8.8%37.5K after |